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Interferon-γ (IFN-γ) triggers macrophage for inflammation response by activating the intracellular JAK−STAT1 signaling.
Suppressor of cytokine signaling 1 (SOCS1) and protein tyrosine phosphatases can negatively modulate IFN-γ signaling. Here, we
identify a novel negative feedback loop mediated by STAT3−SOCS3, which is tightly controlled by SENP1 via de-SUMOylation of
protein tyrosine phosphatase 1B (PTP1B), in IFN-γ signaling. SENP1-deficient macrophages show defects in IFN-γ signaling and
M1 macrophage activation. PTP1B in SENP1-deficient macrophages is highly SUMOylated, which reduces PTP1B-induced
de-phosphorylation of STAT3. Activated STAT3 then suppresses STAT1 activation via SOCS3 induction in SENP1-deficient macro-
phages. Accordingly, SENP1-deficient macrophages show reduced ability to resist Listeria monocytogenes infection. These results
reveal a crucial role of SENP1-controlled STAT1 and STAT3 balance in macrophage polarization.
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Introduction
Microenvironment signals including cytokines, growth factors,
and microorganism-associated molecular patterns drive macro-
phage polarization. These signals activate stimulus-specific tran-
scription factors, which is likely to dictate the functional
polarization of macrophages through effects on inducible gene
promoters with specific features (Stark and Darnell, 2012). For
example, type II interferon (IFN-γ) signaling activates the canonical
JAK−STAT1 pathway leading to macrophage function toward the
M1 phenotype, whereas interleukin (IL-4) or IL-13 activates the
JAK−STAT6 pathway leading to macrophage function toward
the M2 phenotype (Levy and Darnell, 2002; Ramana et al., 2002).
In addition, IL-10 activates the JAK−STAT3 pathway that is asso-
ciated with M2-like macrophages (Yu et al., 2009). Thus, STATs
are pivotal factors in regulating macrophage polarization.
The STAT family consists of seven members (Darnell et al.,
1994; Stark and Darnell, 2012). Among them, STAT1 is activated
by IFN-γ (Levy and Darnell, 2002; Ramana et al., 2002; Varinou
et al., 2003) during M1 macrophage activation. As a down-
stream target of cytokine or growth factor receptors, STAT3
always induces expressions of genes (Il10, Tgfb1, Mrc1) asso-
ciated with M2-like macrophage phenotype to counteract
inflammation induced by STAT1 (Hong et al., 2002; Qing and
Stark, 2004; Regis et al., 2008). Interestingly, STAT1 and STAT3
activation can be regulated reciprocally (Regis et al., 2008). For
example, IFN-γ activates macrophages through STAT3 signaling
in Stat1−/− cells. STAT1 can thus function as a dominant regula-
tor to suppress STAT3 activity in response to IFN-γ signaling.
Received March 14, 2016. Revised June 16, 2016. Accepted October 3, 2016.
© The Author (2016). Published by Oxford University Press on behalf of Journal of
Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.
 Journal of Molecular Cell Biology Advance Access published October 26, 2016
 by guest on D
ecem
ber 27, 2016
http://jmcb.oxfordjournals.org/
D
ow
nloaded from
 
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Yu, T., Zuo, Y., Cai, R., Huang, X., Wu, S., Zhang, C., … Cheng, J. (2017). SENP1 regulates IFN-γ−STAT1 signaling through STAT3−SOCS3 
negative feedback loop. Journal of Molecular Cell Biology, 9(2), 144–153. https://doi.org/10.1093/jmcb/mjw042
The mechanisms by which STAT1 inhibits STAT3 remain unclear
but may include the competition for binding to docking sites of
IFN-γ receptors, tyrosine kinases, or other protein factors that
required for STAT activation. The disruption of STAT1:STAT3 bal-
ance may lead to certain pathological conditions.
IFN produced by activated T cells or NK cells is responsible for
M1 macrophage activation (Hu et al., 2002). Biochemical and gen-
etic studies showed that IFN-γ signal is mainly mediated by JAK1/
2−STAT1 signaling pathway (Fu et al., 1990; Flynn et al., 1993;
Darnell et al., 1994; Durbin et al., 1996; Meraz et al., 1996;
Platanias, 2005; Yu et al., 2009; Stark and Darnell, 2012). IFN-γ
binds to its cell-surface receptor, triggers receptor-associated JAK1
and JAK2 auto-phosphorylation, and followed by phosphorylation
of an IFNγR1 tyrosine residue, which serves as a docking site pre-
dominantly for STAT1 (Darnell et al., 1994; Sakatsume et al.,
1995; Bach et al., 1996; Kaplan et al., 1996; Bach et al., 1997;
Pestka et al., 2004; Platanias, 2005; Stark and Darnell, 2012).
IFNγR1-recruited STAT1 is phosphorylated on tyrosine 701 by JAK,
dimerizes, and then translocates to the nucleus where it can bind
to a regulatory DNA element termed gamma-activated sequence
(GAS), which is important for regulating gene expression (Levy
and Darnell, 2002; Varinou et al., 2003; Qing and Stark, 2004;
Stark and Darnell, 2012). Major mechanisms that are responsible
for negative regulation of IFN-γ signaling in cells include STAT de-
phosphorylation by tyrosine phosphatases and JAK catalytic inhib-
ition by suppressor of cytokine signaling 1 (SOCS1) protein (David
et al., 1993; Alexander et al., 1999; Marine et al., 1999; Chen
et al., 2000; Kinjyo et al., 2002; ten Hoeve et al., 2002). SOCS1 is
a target gene in IFN-γ signaling. Thus, IFN-γ induces SOCS1 feed-
back inhibition of JAK to restrain its own activity (Alexander et al.,
1999; Marine et al., 1999; Chen et al., 2000; Kinjyo et al., 2002).
SUMO (also called Sentrin) is a novel ubiquitin-like protein that
can covalently modify a large number of proteins. SUMO modifica-
tion has now emerged as an important regulatory mechanism in
many signaling pathways through alternations of its targeting pro-
tein functions. SUMOylation is catalyzed by activating enzyme
(E1), conjugating enzyme (E2), as well as ligating enzyme (E3). It
can be reversed by a family of Sentrin/SUMO-specific proteases
(SENPs) (Hay, 2007; Yeh, 2009). Mounting evidence demonstrates
that SENP family members play crucial roles in determining the
protein SUMOylation status and activity (Cheng et al., 2007; Hay,
2007; Yeh, 2009). We previously reported that SENP1 is involved
in hypoxia signaling, angiogenesis, T and B cell development, and
mitochondrial biogenesis via de-SUMOylation of distinct targets
(Cheng et al., 2007; Cai et al., 2012; Van Nguyen et al., 2012).
Here, we report SENP1 as a crucial regulator in IFNγ−STAT1 sig-
naling as well as M1 macrophage polarization. SENP1-deficient
macrophages show defects in IFN-γ signaling and M1 macrophage
activation. We further observe that protein tyrosine phosphatase
1B (PTP1B) is highly SUMOylated in SENP1-deficient macro-
phages, which reduces its phosphatase activity in STAT3 de-
phosphorylation. Activated STAT3 in SENP1-deficient macrophages
then suppresses STAT1 activation through SOCS3 induction, and
consequently induces the downregulation of IFN-γ signaling as
well as M1 polarization.
Results
SENP1 is essential for IFN-γ signaling in macrophages
To examine whether SENP1 plays a role in macrophage activa-
tion, we first treated the macrophages, which were isolated
from Senp1+/+ or Senp1−/− fetal livers, with IFN-γ, an inducer
for M1 macrophage activation. The induction of IFN-γ-dependent
genes was impaired in Senp1−/− macrophages compared with
Senp1+/+ macrophages (Figure 1A). The peritoneal macro-
phages obtained from Senp1+/− mouse (Supplementary
Figure S1) or Senp1-silenced RAW264.7 cells (Supplementary
Figure S2) also showed similar defects in the expression of
these genes (Figure 1B and Supplementary Figure S3), suggest-
ing an essential role of SENP1 in IFN-γ-induced gene expression.
We then overexpressed SENP1 and SENP1 catalytic mutant in
THP-1 cells. The expression of SENP1 but not its catalytic
mutant induced the expression of IFN-γ-dependent genes com-
parable to IFN-γ treatment (Figure 1C), indicating that de-
SUMOylation activity is requested for SENP1 to promote IFN-γ
activation. We further analyzed the activation status of STAT1, a
key transcription factor activated by IFN-γ in SENP1-deficient
macrophages. As shown in Figure 1D, IFN-γ-induced phosphoryl-
ation of STAT1 (Y701) was significantly reduced in Senp1−/−
macrophages or Senp1+/− macrophages compared with Senp1
+/+ macrophages. We observed similar changes in si-SENP1-
RAW264.7 cells in comparison with the control macrophages
(Supplementary Figure S4).
STAT3−SOCS3 mediates an alternative feedback inhibition of
IFN-γ signaling in SENP1-deficient macrophages
To understand how IFN-γ signaling is impaired in SENP1-
deficient macrophages, we determined the IFN-γ-induced JAK1
and JAK2 activation. We observed that JAK2 but not JAK1 activa-
tion decreased in SENP1-deficient macrophages (Figure 2A and
Supplementary Figure S4). However, the impaired JAK2 activa-
tion was not attributed to defective IFN-γ receptor expression in
SENP1-deficient macrophages, as IFNγR1 and IFNγR2 expres-
sions in Senp1−/− macrophages were elevated (Supplementary
Figure S5), which might be a compensation response to the
defect in IFN-γ signaling.
Given the fact that JAK activity is negatively regulated by SOCS-
mediated feedback loop (Chen et al., 2000; Krebs and Hilton,
2001; Kinjyo et al., 2002), we explored whether SOCS activity
contributed to the downregulation of JAK2 in SENP1-deficient
macrophages. SOCS1, a well-known negative regulator of the JAK
−STAT1 pathway (Alexander et al., 1999; Krebs and Hilton, 2001),
was decreased upon IFN-γ treatment in these Senp1-silenced
macrophages (Figure 2B). In contrast, SOCS3, a negative feed-
back regulator of the JAK−STAT3 pathway, markedly increased in
these Senp1-silenced macrophages upon treatment (Figure 2B
and C). Since SOCS3 negatively regulates JAK activity in macro-
phages in response to IL-6 stimulation (Croker et al., 2003),
we speculated that increased expression of SOCS3 might be
responsible for the downregulation of JAK2 activity in SENP1-
deficient macrophages. To verify this, we silenced Socs3 in si-
SENP1-RAW264.7 cells (Supplementary Figure S6) and examined
2 j Yu et al.
 by guest on D
ecem
ber 27, 2016
http://jmcb.oxfordjournals.org/
D
ow
nloaded from
 
the gene induction by IFN-γ in these cells. As shown in Figure 2D,
silencing Socs3 significantly increased the expression of IFN-γ-
induced target genes in si-SENP1-RAW264.7 cells. JAK2 phosphor-
ylation was also restored in these cells with silenced Socs3
(Figure 2E). These results indicate that SOCS3 is responsible for
IFN-γ-induced reduction of JAK2−STAT1 activity in SENP1-
deficient macrophages.
We further testified whether SOCS3 expression resulted from
IFN-γ-induced STAT3 activation in SENP1-deficient macrophages.
Indeed, we found that IFN-γ robustly induced STAT3 tyrosine
Figure 1 SENP1 is essential for the activation of IFN-γ signaling. (A) IFN-γ-induced gene expression in Senp1−/− macrophages was lower than
that in Senp1+/+ cells. The data were measured by real-time PCR and presented as mean ± SD of three independent experiments. Differences
between Senp1+/+ and Senp−/− macrophages were significant (P < 0.005, t-test). (B) IFN-γ-induced gene expression in Senp1+/− macro-
phages was lower than that in Senp1+/+ cells. The data were measured by real-time PCR and presented as mean ± SD of three independent
experiments. Differences between Senp1+/+ and Senp1+/− macrophages were significant (P < 0.005, t-test). (C) SENP1 overexpression upre-
gulated IFN-γ target genes. Expression of IFN-γ target genes in THP-1 cells transfected with SENP1 wild-type (SENP1wt) or SENP1 mutant
(SENP1mut) or treated with IFN-γ (10 ng/ml) was measured by real-time PCR. The data are presented as mean ± SD of three independent
experiments. Differences between SENP1wt- and SENP1mut-transfected THP-1 cells, SENP1wt- and empty vector-transfected THP-1 cells, or IFN-
γ-treated and empty vector-transfected THP-1 cells were significant (P < 0.005, t-test). (D) SENP1 deficiency reduced STAT1 activation by IFN-γ.
STAT1 in fetal liver macrophages from Senp1+/+ and Senp1−/− mice (left panel) and peritoneal macrophages from Senp1+/+ and Senp1+/−
mice (right panel) were analyzed by blotting with anti-total or phosphotyrosine antibody as indicated.
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phosphorylation in Senp1−/− macrophages (Figure 2F).
Similarly, IFN-γ-induced STAT3 phosphorylation was significantly
increased in Senp1+/− macrophages as well as in Senp1-
silenced Raw264.7 cells (Supplementary Figure S7). All
together, these data support that the STAT3−SOCS3 axis tightly
controls IFN-γ signaling in SENP1-deficient macrophages.
SENP1 negatively regulates STAT3 activity by deSUMOylating
PTP1B
STAT3 phosphorylation status in cells is an indicator of the bal-
ance between JAK tyrosine kinase and the phosphatases respon-
sible for STAT3 de-phosphorylation (Regis et al., 2008). Since
SENP1-deficient macrophages showed downregulation of JAK2
specifically in response to IFN-γ, we postulated that IFN-γ-induced
STAT3 activation might result from the reduction of phosphatase-
mediated de-phosphorylation in SENP1-deficient macrophages.
PTP1B and TCPTP are two well-recognized tyrosine phosphatases,
which are important for STAT3 de-phosphorylation (ten Hoeve
et al., 2002; Zabolotny et al., 2002; Xu and Qu, 2008). Cells were
treated with either PTP1B-specific inhibitor or TCPTP-specific
inhibitor. As shown in Supplementary Figure S8, IFN-γ-induced
STAT3 phosphorylation was significantly increased in PTP1B-
specific inhibitor-treated macrophages but not in TCPTP inhibitor-
treated samples, indicating that PTP1B is a tyrosine phosphatase
in response to STAT3 de-phosphorylation in macrophages.
Figure 2 STAT3−SOCS3 mediates an alternative feedback inhibition in IFN-γ signaling. (A) IFN-γ-induced JAK2 but not JAK1 phosphoryl-
ation was reduced in SENP1-deficient macrophages. JAK1 and JAK2 in Senp1+/+ and Senp1−/− macrophages (left panel) or Senp1+/+ and
Senp1+/− macrophages (right panel) were analyzed by blotting with JAK1, JAK2, pY-JAK1, or pY-JAK2 antibody as indicated. (B) SENP1 defi-
ciency decreased Socs1 but enhanced Socs3 expression. IFN-γ-induced expressions of Socs1 and Socs3 in RAW264.7 cells transfected with
si-SENP1 or control were measured by real-time PCR. The data are presented as mean ± SD of three independent experiments. Differences
between IFN-γ-treated si-SENP1-RAW264.7 and control cells were significant (P < 0.005, t-test). (C) SENP1 deficiency enhanced SOCS3
expression. SOCS3 expression in peritoneal macrophages from Senp1+/+ and Senp1+/− mice was blotted with anti-SOCS3 antibody.
(D) Silencing Socs3 rescued SENP1 deficiency-caused downregulation of IFN-γ target genes. The expression of IFN-γ-induced genes was
measured by real-time PCR in RAW264.7 macrophages transfected with si-SENP1, si-SOCS3, or control as indicated. The data are pre-
sented as mean ± SD of three independent experiments. (E) Silencing Socs3 rescued SENP1 deficiency-caused downregulation of JAK2.
JAK2 protein was analyzed in western blot with JAK2 antibody or phosphotyrosine antibody in RAW264.7 macrophages transfected with
either si-SENP1 or si-SOCS3, or treated with IFN-γ. (F) IFN-γ induced higher level of STAT3 phosphorylation in Senp1−/− macrophages
than in Senp1+/+ cells. STAT3 expression in macrophages from Senp1+/+ and Senp1−/− fetal livers was blotted with anti-total or phos-
photyrosine antibody as indicated.
4 j Yu et al.
 by guest on D
ecem
ber 27, 2016
http://jmcb.oxfordjournals.org/
D
ow
nloaded from
 
Previous studies have reported that PTP1B is a SUMOylated
protein (Dadke et al., 2007). To reveal whether PTP1B is a
SENP1 target in STAT3 regulation, we analyzed PTP1B SUMOyla-
tion status in Senp1−/− cells in comparison with Senp1+/+
cells. We observed an accumulation of SUMOylated PTP1B pro-
tein in Senp1−/− but not in Senp1+/+ cells (Figure 3A), indicat-
ing that SENP1 functions as a specific de-SUMOylation protease
for PTP1B. SUMOylated PTP1B impairs its intrinsic phosphatase
activity (Dadke et al., 2007). We treated cells with PTP1B-
specific inhibitor, and found that PTP1B inhibition augmented
STAT3 phosphorylation but reduced STAT1 activation, which
mimicked the response of SENP1-deficient macrophages to IFN-γ
signal (Figure 3B). We next performed in vitro de-phosphorylation
assay, which showed that SUMOylated PTP1B had less phosphat-
ase activity to STAT3 (Supplementary Figure S9). We further
transfected PTP1B wild-type (WT) or PTP1B SUMO mutant (KR)
plasmids into SENP1-deficient Raw264.7 cells. Although the
expression of STAT1 target genes Cxcl9, Cxcl10, and Irf1 was
upregulated in both PTP1B WT and PTP1B KR-transfected cells,
PTP1B KR certainly demonstrated a stronger activity in upregulat-
ing the expression of these genes than PTP1B WT (Figure 3C).
These data together indicate that the accumulation of SUMOylated
PTP1B contributes to STAT3−SOCS3 activation and subse-
quently inactivates IFN-γ–STAT1 signaling in SENP1-deficient
macrophages.
IFN-γ induces SENP1 expression
Since SENP1 acts as a positive regulator in IFN-γ signaling
via inhibition of a STAT3−SOCS3-mediated negative feedback
loop, we thought that IFN-γ would induce SENP1 expression to
promote macrophage activation. As expected, Senp1 mRNA
level was significantly increased in IFN-γ-treated macrophages
(Figure 4A). We further validated this result by detecting the ele-
vated SENP1 protein level in THP-1 cells post IFN-γ treatment
(Figure 4B). Analysis of sequence upstream to Senp1 promoter
showed a GAS element located at −68 to −59 bp of Senp1 pro-
moter. We verified this GAS element in a SENP1 promoter-
luciferase reporter construct, and found that IFN-γ significantly
induced the transcription of Senp1 promoter reporter gene
(Figure 4C). In contrast, the mutation in the GAS sequence of
Senp1 promoter completely abolished IFN-γ-induced Senp1 tran-
scription. We then performed ChIP assay to confirm that STAT1
was bound to the Senp1 promoter in response to IFN-γ signal
(Figure 4D).
Figure 3 SUMOylated PTP1B is accumulated in SENP1-deficient macrophages and reduces PTP1B inhibition of STAT3 in IFN-γ signaling.
(A) SUMOylated PTP1B was accumulated in Senp1−/− fetal liver macrophages. PTP1B was immunoprecipitated by anti-PTP1B antibody and
blotted with anti-PTP1B or anti-SUMO1 antibody. (B) PTP1B inhibitor increased STAT3 phosphorylation but decreased STAT1 phosphoryl-
ation in macrophages. STAT proteins were analyzed in western blot with STAT1, STAT3, phospho-STAT1, or phospho-STAT3 antibody in
Senp1+/+ or Senp1+/− macrophages treated with PTP1B inhibitor or IFN-γ as indicated. (C) PTP1B SUMO mutant (KR) rescued SENP1
deficiency-caused downregulation of IFN-γ target genes. si-SENP1-Raw264.7 cells were infected with retrovirus (pMSCV vector) encoding
flag-PTP1B WT or KR (K73, 335, 347, and 389 R). The expression of Cxcl9, Cxcl10, and Irf1 was analyzed by real-time PCR in cells with or
without IFN-γ treatment.
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Defect in M1 macrophage polarization in Senp1+/− mice
To further explore the role of SENP1 in regulating macro-
phage polarization, the bone marrow (BM)-derived macro-
phages extracted from both Senp1+/+ and Senp1+/− mice
were treated with recombinant IFN-γ (10 ng/ml),
lipopolysaccharide (LPS), or IFN-α, respectively (in vitro). We
stained the macrophages with F4/80, CD11b, CD11c, and
CD206 fluorochrome-conjugated antibodies after 24 h cultur-
ing. The proportion of M1 (CD11c+CD206−) or M2
(CD11c−CD206+) population in total macrophages (F4/
80+CD11b+) was analyzed by flow cytometry. As shown in
Figure 5A, Senp1+/+ macrophages were activated and polar-
ized to M1 phenotype upon stimulation with IFN-γ or LPS, but
not with IFN-α. The percentage of M1 increased to 23.9%
after IFN-γ stimulation or 17.7% after LPS stimulation as com-
pared with medium control at 7.52%. In contrast, Senp1+/−
macrophage stimulated with IFN-γ had only marginal increase
in the percentage of M1 with 12.6% compared with control at
7.97%, suggesting that SENP1 is essential for IFN-γ-induced
M1 macrophage polarization. Interestingly, we detected similar
extent of M1 increase (16.7%) in Senp1+/− macrophages as in
Senp1+/+ cells in response to LPS stimulation, suggesting
that LPS-induced M1 phenotype of macrophage activation is
not dependent on SENP1 regulation. No changes in M2 pro-
portion in Senp1+/+ macrophages were observed after all
three stimuli, whereas a little decrease in M2 proportion in
Senp1+/− was detected upon IFN-γ stimulation but not upon
LPS stimulation (Figure 5A and B).
SENP1-deficient macrophages show reduced ability to resist
Listeria monocytogenes infection
We performed the bacterial killing assay to testify the
defects in M1 activation in Senp1+/− macrophages. The num-
bers of intracellular bacteria were determined in L. monocyto-
genes-infected Senp1+/+ and Senp1+/− macrophages. As
shown in Figure 5C, Senp1+/− macrophages had 10 times
more bacteria load than Senp1+/+ cells (Figure 5C). We then
infected Senp1+/+ or Senp1+/− mice with L. monocytogenes,
and counted bacterial colony-forming units (CFUs) in livers and
spleens from infected mice at 48 h after infection. Figure 5D
illustrated that Senp1+/− mice had significantly higher CFUs
than Senp1+/+ mice. These results suggest that SENP1 is
essential for M1 activation in macrophages.
We further determined whether the role of SENP1 in anti-
bacteria defense relates to STAT1:STAT3 activation in macro-
phages. As shown in Figure 5E, Senp1+/− macrophages pretreated
with STAT3 inhibitor JSI-124 showed increased STAT1 activa-
tion and became more resistance to L. monocytogenes infec-
tion than un-pretreated Senp1+/− macrophages, suggesting
that hyper-activation of STAT3 is a factor leading to the failure
of anti-bacteria defense in SENP1-deficient macrophages.
Discussion
In this study, SENP1-deficient macrophages show the
reduced IFN-γ signaling for M1 activation. We have identified a
STAT3−SOCS3-mediated alternative negative feedback loop in
IFN-γ signaling, which is tightly controlled by SENP1 through
Figure 4 IFN-γ induces SENP1 expression. (A) IFN-γ-induced Senp1 transcripts. Senp1 mRNA level was measured in macrophages stimulated
with IFN-γ (10 ng/ml) for 2 h. The data are presented as mean ± SD of three independent experiments. Difference between macrophages
with and without IFN-γ treatment was significant (P < 0.005, t-test). (B) IFN-γ treatment increased SENP1 protein level. Expression of SENP1
was analyzed by flow cytometry in THP-1 cell treated with or without IFN-γ (10 ng/ml) for 24 h. (C) GAS site was identified on mouse Senp1
promoter. RAW264.7 cells were transfected with empty vector, SENP1 promoter luciferase, or GAS site-mutated SENP1 promoter luciferase
as indicated. The cells were treated with IFN-γ (10 ng/ml) for 30 min at 24 h after transfection. The luciferase activity was measured, and
the data are presented as mean ± SD of three independent experiments. Difference between SENP1-luc-transfected RAW264.7 cells with
and without IFN-γ treatment was significant (P < 0.005, t-test). (D) IFN-γ promoted STAT1 occupancy at Senp1 promoter. STAT1 occupancy
at Senp1 promoter was analyzed by qChIP assays in macrophages treated with or without IFN-γ (10 ng/ml). The data are presented as
mean ± SD of three independent experiments. Difference between macrophages with and without IFN-γ treatment was significant
(P < 0.005, t-test).
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de-SUMOylation of PTP1B. Furthermore, in SENP1-deficient
macrophages, the accumulation of SUMOylated PTP1B induces
an increase in phosphorylated STAT3 to promote SOCS3 expres-
sion and eventually leads to suppression of STAT1 signaling.
Thus, SENP1 determines macrophage fate by balancing STAT1:
STAT3 activation (Figure 6).
The STAT1 pathway is the key player in controlling the expres-
sion of immune effector genes in classical M1 macrophage acti-
vation (Darnell et al., 1994). Since IFN-γ could induce STAT3
activation in Stat1−/− cells, STAT1 is supposed to suppress
STAT3 activity (Qing and Stark, 2004). In this study, we found
that STAT1 activation induces SENP1 expression, which inhibits
STAT3−SOCS3 via de-SUMOylation of PTP1B to enhance STAT1
signaling. Therefore, STAT3 can also suppress STAT1 activity
through SOCS3.
Our previous studies have identified SENP1 as a critical regulator
in erythroid and lymphoid cell development (Cheng et al., 2007;
Figure 5 SENP1 is essential for M1 polarized phenotype of macrophages. (A) IFN-γ-induced M1 macrophages were reduced in Senp1−/−
mice. Senp1+/+ and Senp1+/− macrophages were treated with recombinant IFN-γ, LPS, or IFN-α in vitro. After 24 h in culture, the propor-
tion of M1 (CD11c+CD206−) or M2 (CD11c−CD206+) population in total macrophages (F4/80+CD11b+) was analyzed by flow cytometry with
CD11c and CD206 fluorochrome-conjugated antibodies. (B) Quantification of M1 or M2 population in macrophages from Senp1+/+ and
Senp1+/− mice (n = 4) treated with recombinant IFN-γ, LPS, or IFN-α in vitro. (C) The bacteria killing in Senp1+/− macrophages was lower
than that in Senp1+/+ cells. Senp1+/+ and Senp1+/− macrophages were infected with L. monocytogenes a multiplicity of infection (MOI) of
3. The macrophages were collected at the indicated times (top panel) and lysed and dilution plated to determine bacterial burdens. The
data are presented as mean ± SD. Differences between Senp1+/+ and Senp1+/− macrophages were significant (*P < 0.005, t-test). (D) The
bacteria killing in Senp1+/− mice was lower than that in Senp1+/+ mice. Senp1+/+ and Senp1+/− mice (n = 5) were infected with a dose
of L. monocytogenes (10000 CFU). Spleens and livers were harvested 2 days later and homogenized and dilution plated to determine bac-
terial burdens. The data are presented as mean ± SD. Differences between Senp1+/+ and Senp1+/− mice were significant (*P < 0.005, t-
test). (E) STAT3 inhibitor promoted the bacteria killing in Senp1+/− macrophages. Senp1+/− macrophages were pretreated with STAT3
inhibitor JSI-124 (0.5 μM) or vehicle control. At 6 h after pre-treatment, these cells were infected with L. monocytogenes at an MOI of 3. The
macrophages were collected at 0 and 24 h and lysed and dilution plated to determine bacterial burdens. The data are presented as
mean ± SD. Differences between JSI-124-pretreated and vehicle control macrophages were significant (*P < 0.005, t-test). Right panel
shows the level of STAT1, phospho-STAT3, STAT3, or phospho-STAT3 in the infected macrophages at 24 h after infection.
Figure 6 A model depicting the role of SENP1 in modulating IFN-γ−
STAT1 signaling.
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Van Nguyen et al., 2012). Here, we show a previously unexplored
aspect of SENP1 function in the regulation of macrophage activa-
tion by targeting a phosphatase PTP1B. SUMOylation represses
the de-phosphorylation activity of PTP1B and inhibits the nega-
tive effect of PTP1B on insulin receptor signaling as well as trans-
formation by the oncogene v-crk (Dadke et al., 2007). This study
shows that SUMOylation of PTP1B can reduce its inhibition to
STAT3 in IFN-γ signaling. Therefore, our studies support the pro-
posal that the function of SENP1 as a positive regulator in STAT1-
induced macrophage activation is mainly through de-SUMOylation
of PTP1B, which reduces inhibition of STAT3−SOCS3 on STAT1
signaling. PTP1B engagement is well known for the regulation
of insulin-stimulating signaling (Yip et al., 2010). Our study
shows that PTP1B is also essential for IFNγ-induced macro-
phage activation.
We further demonstrate the role of SENP1 in controlling
the balance of STAT1:STAT3 activation. SENP1 shows as a
suppressor of STAT3 and promotes STAT1 activation. Interest-
ingly, we could not detect any difference in STAT1 activation
between LPS or IFN-α-treated Senp1+/+ and Senp1+/− macro-
phages, although both stimuli can activate STAT1 signaling.
LPS stimulates M1 macrophage phenotype mainly through
the TLR−NF-κB pathway and STAT1 signaling through the
auto-secretion of IFN-β. IFN-α stimulation promotes the for-
mation of ISGF3γ (STAT1:STAT2:IRF9) complex to regulate the
expression of genes with the promoters containing IFN-stimu-
lated response element (IRSE) sequence. Both signaling path-
ways do not include STAT3 engagement, indicating that
STAT3 is essential for SENP1 to target STAT1 pathway activa-
tion. Interestingly, STAT3 is an important regulator in tumori-
genesis. Whether SENP1 could control tumorigenesis via
modulating STAT3 activity is worth investigating in future.
Materials and methods
Mice
Senp1+/− mice were generated as previously described
(Cheng et al., 2007). Mice were maintained at the Shanghai Jiao
Tong University School of Medicine animal facility. All animal
experiments were performed with the approval of Shanghai Jiao
Tong University School of Medicine Committee on Animal Care.
Antibodies and reagents
Antibodies for pY1022/Y1023-JAK1, pY1007/Y1008-JAK2,
pY701-STAT1, pY705-STAT3, JAK1, JAK2, STAT1, STAT3, and
SOCS3 were purchased from Cell Signaling Technology. SENP1
antibody was generated by immunizing rabbit with human
SENP1 peptide (170-183: SPKKTQRRHVSTAE) (Wang et al.,
2013). PTP1B inhibitor (CAS 765317-72-4) was purchased from
Santa Cruz Biotech. TCPTP inhibitor Compound 8 was from
Zhong-Yin Zhang at Indiana University School of Medicine
(Zhang et al., 2009). STAT3 inhibitor JSI-124 was purchased
from Calbiochem (EMD Biosciences, Inc.), Recombinant mouse
IFN-γ was purchased from R&D Systems.
SENP1-silenced RAW264.7 macrophages
RAW264.7 cells were infected by retrovirus encoding non-
specific (NS) or Senp1-specific shRNA (si-SENP1, 5′-GCAGGAT
CCTCTTGCAATA-3′) and selected in medium containing 3 μg/ml
puromycin.
Preparation of fetal liver macrophages
Fetal liver macrophages were prepared from the livers of
E13.5 embryos as previously described (Morris et al., 1988).
Real-time quantitative PCR
Total RNA was isolated by the TRIzol kit (Invitrogen). RNA was
treated with DNase (Promega). Complementary DNA was synthe-
sized using the cDNA synthesis kit (Takara Bio Inc.) according to
the manufacturer’s instructions. Fluorescence real-time RT-PCR
was performed with the SYBR Green PCR Core Reagents of (PE
Biosystems) on the ABI PRISM 7300 system (PerkinElmer Life
Sciences). All data were analyzed by ABI PRISM SDS software
version 2.0 (PerkinElmer Life Sciences). Pairs of PCR primers
used to amplify the target genes were listed in Table 1.
Clearance of pathogens in vivo and in vitro
Senp1+/+ and Senp1+/− mice (6–8 weeks old) were infected
(tail vein) with 1 × 104 CFU of log-phase L. monocytogenes
strain. After 48 h, livers and spleens were harvested for bacteria
CFU counting. Briefly, liver or spleen homogenate was coated on
the no antibiotic plate by gradient dilution and culture at 37°C
Table 1 Primers used for RT-PCR.
Gene Primer
Ifnγr1 5′-TGGGCCAGAGTTAAAGCTAAG-3′ (forward)
5′-GTGAAATACGAGGACGGAGAG -3′ (reverse)
Ifnγr2 5′-GATTCTAACTTGGGAGCCGTC-3′ (forward)
5′-ACTTTGTCTCTGTGATGTCCG-3′ (reverse)
Ifnγ 5′-GGCCATCAGCAAAACATAAGCGT-3′ (forward)
5′-TGGGTTGTTGACCTCAAACTTGGC-3′ (reverse)
Irf1 5′-TGGAGATGTTAGCCCGGACACTTT-3′ (forward)
5′- ACGGTGACAGTGCTGGAGTTATGT-3′ (reverse)
Iigp1 5′-AAGCGGCAATTTCTGAAGCAGAGG-3′ (forward)
5′-ATCCACTCCAAACACAGTGCGGTA-3′ (reverse)
Socs1 5′-AGTCGCCAACGGAACTGCTTCTT-3′ (forward)
5′-ACGTAGTGCTCCAGCAGCTCGA AA-3′ (reverse)
Socs3 5′-CCAGCATCTTTGTCGGAAGACTGT-3′ (forward)
5′- TCATACTGATCCAGGAACTCCCGA-3′ (reverse)
Cxcl9 5′-ATCTTCCTGGAGCAGTGTGGAGTT-3′ (forward)
5′-AGGGATTTGTAGTGGATCGTGCCT-3′ (reverse)
Cxcl10 5′-ATATCGATGACGGGCCAGTGAGAA-3′ (forward)
5′-AATGATCTCAACACGTGGGCAGGA-3′ (reverse)
Ifi203 5′-TGTCAGGTGTGAACCAGGCAGTAA-3′ (forward)
5′-ACTGAGTCTGGGTTGAGTGGCTTT-3′ (reverse)
Ifi204 5′-GTGCTCACTGCAACAGACCCATTT-3′ (forward)
5′-TCTCCAGGATGCCTTTGCTCTCAA-3′ (reverse)
Ly6e 5′-ATGTCAACCTTGGCTACACCCTGA-3′ (forward)
5′-AGAGCCAACAAGCTAAGCAGGAGT-3′ (reverse)
Nos2 5′-CTGCTGGTGGTGACAAGCACATTT-3′ (forward)
5′-ATGTCATGAGCAAAGGCGCAGAAC-3′ (reverse)
Senp1 5′-AGCTGCCCAAGAAACCAGGAAA-3′ (forward)
5′-AATGGTCAAGCGGAATGCCT-3′ (reverse)
Gapdh 5′-CATGTTCGTCATGGGTGTGAACCA-3′ (forward)
5′-AGTGATGGCATGGACTGTGGTCAT-3′ (reverse)
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for 12–18 h. Then, 30−300 colonies were selected for counting
and the total number of bacteria was calculated according to
the dilution fold.
Macrophages differentiated from BM of Senp1+/+ or Senp1+/−
mice (6−8 weeks old) were cultured with L. monocytogenes for
3 h (MOI = 3, i.e. bacteria number:cell number = 3:1). The
medium was altered and gentamicin was added for additional 1-
h incubation in order to kill the pathogens adherent to cell
membrane or uninfected cells. The cells were cracked by lysis
buffer (1% Triton X-100) at various time points, and spread on
the plates with a gradient dilution method. Plates of 30–300 col-
onies were selected for counting and then the total number of
the pathogens was calculated according to the dilution fold.
Statistics
Results were shown as mean ± SD. Statistical analyses
represent a non-parametric Student’s t-test, and null hypoth-
eses were rejected at P < 0.05.
Supplementary material
Supplementary material is available at Journal of Molecular
Cell Biology online.
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